GlassScriptPhysician profile
Henry Rex Greene
NPI 1659312627
$551.44
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.36 · 2020: $405 · 2021: $29.76 · 2022: $31.03.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $127.81 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $108.89 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $60.79 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.01 | 2019 | |
| Abbvie INC. | $31.06 | 2020 | |
| Foundation Medicine, INC. | $24.01 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $23.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.52 | 2020 | |
| Daiichi Sankyo INC. | $20.69 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.90 | 2020 | |
| Dova Pharmaceuticals | $18.86 | 2020 | |
| Glaxosmithkline, LLC. | $18.70 | 2020 | |
| Pfizer INC. | $16.96 | 2020 | |
| Incyte Corporation | $14.08 | 2020 | |
| Sun Pharmaceutical Industries INC. | $11.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.